Discovery of novel antagonists on β2 -adrenoceptor from natural products using a label-free cell phenotypic assay

Naunyn-Schmiedeberg's Archives of Pharmacology
Pengyu ZhangXinmiao Liang

Abstract

Label-free cell phenotypic assays were performed to establish a β2-adrenoceptor (β2-AR) target model in A431 cells and a β1-AR target model in transfected HEK293-β1 cells, using known β2-AR and β1-AR agonists and antagonists. A list of natural compounds was screened on the target models, among which seven new compounds were found to be antagonistically active against β2-AR. After receptor specificity evaluations on hydroxyl carboxylic acid receptor-2 (ΗΧΑ-2), histamine receptor (H1R), and β1-adrenoceptor (β1-AR), six out of the seven compounds, including nuciferine, epiberberine, harmaline, harmine, palmatine, and columbamine, exhibited specific antagonistic activity against β2-AR. Epiberberine and palmatine showed the strongest antagonistic activities against β2-AR with IC50 values of 2.3 ± 0.2 μM and 2.6 ± 0.3 μM, respectively. Docking palmatine to the crystal structure of human β2-AR (PDB 5X7D) suggested that the ligand forms a hydrogen bond with N312 and hydrophobic interaction with several amino acid residues in the binding pocket, such as D113 and V114. The kinetic binding profile of palmatine was further investigated using co-stimulation assays. Results suggested that palmatine was a competitive antagonist for β2-AR. The...Continue Reading

References

Jan 3, 2006·The Journal of Allergy and Clinical Immunology·Malcolm Johnson
Jan 9, 2007·Journal of Pharmacological and Toxicological Methods·Ye FangAnn M Ferrie
Apr 4, 2009·Proceedings of the National Academy of Sciences of the United States of America·Peter KolbBrian K Shoichet
Jan 24, 2013·Journal of Pharmacological and Toxicological Methods·Ye Fang
Apr 12, 2014·Frontiers in Pharmacology·Ye Fang
Mar 4, 2015·Basic & Clinical Pharmacology & Toxicology·Filip Y FiskerMarkus Wehland
Feb 9, 2016·Journal of Natural Products·David J Newman, Gordon M Cragg
Mar 11, 2016·PloS One·Martilias S FarrellBryan L Roth
Jan 1, 2015·Evidence-based Complementary and Alternative Medicine : ECAM·Keshav Raj Paudel, Nisha Panth
May 8, 2016·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Ye Fang
May 25, 2016·Nature Chemistry·Tiago RodriguesGisbert Schneider
Nov 5, 2016·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·S LiebA Buschauer
Apr 1, 2016·Journal of Food and Drug Analysis·Hsin-Yi Hung, Tian-Shung Wu
Sep 19, 2017·Current Hypertension Reports·Steven G Chrysant, George S Chrysant
Nov 7, 2017·American Journal of Ophthalmology·Maria Antonieta GinguerraSuzana Matayoshi
Nov 15, 2017·Journal of Optometry·Patricia LomaJesus Pintor

❮ Previous
Next ❯

Citations

Sep 10, 2019·Phytotherapy Research : PTR·Dominik Tarabasz, Wirginia Kukula-Koch
Jul 12, 2019·Current Vascular Pharmacology·Zhiyong WangHao Li

❮ Previous
Next ❯

Methods Mentioned

BETA
biosensor

Software Mentioned

Epic Imager
GraphPad
Imager Beta
Excel
LeDock
GraphPad Prism

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.